CP3 Director Dr. Walid Gellad discussed Omicron-specific Covid boosters with Politico in Prescription Pulse. He also "expressed concern about the CDC’s history of not highlighting the nuances of the benefit-risk balance of boosting a 40-something with the ancestral strain compared to an 18-year-old man who falls into the myocarditis-risk category."